Leading UK biopharma organizations are spearheading the just-launched "UK/EU Life Sciences Transition Program," to develop a variety of policy options to foster a world-leading life sciences environment in the UK outside of the EU.
The initiative's participants aim to develop a "playbook" of options – from regulatory approaches to intellectual property issues – by...








